AI要約
national pharmacovigilance system oversight のライブ結果 6611 件を確認し、最初に比較する価値が高い 3 件の選択肢に絞りました。
この候補リストで特に強いテーマは Pharmacovigilance と Regulatory Affairs です。
national pharmacovigilance system oversight のライブ結果 6611 件を確認し、最初に比較する価値が高い 3 件の選択肢に絞りました。
この候補リストで特に強いテーマは Pharmacovigilance と Regulatory Affairs です。
情報源: Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych (URPL)
説明
Comprehensive regulatory management of the Polish drug safety framework, including the processing of Adverse Drug Reaction (ADR) reports from both patients and medical professionals, and conducting pharmacovigilance inspections of Marketing Authorisation Holders (MAHs) to ensure GVP compliance.
おすすめ用途
Pharmaceutical companies, Healthcare professionals, Regulatory compliance と Adverse reaction reporting
情報源: Zentiva Group, a.s.
説明
An internal pharmacovigilance management system overseen by an EU QPPV, dedicated to the monitoring and traceability of Zentiva's medicinal products. It facilitates the intake and evaluation of adverse event reports from global markets to maintain patient safety.
おすすめ用途
Zentiva product users, Pharmacists, Drug safety monitoring と Adverse event intake
情報源: BASG - Bundesamt für Sicherheit im Gesundheitswesen
説明
Système officiel autrichien pour la notification et l'évaluation des effets indésirables des médicaments humains et vétérinaires afin de garantir la sécurité continue des patients.
おすすめ用途
Signalement d'effets secondaires, Professionnels de santé, Patients autrichiens と Sécurité post Marché
| 比較 | National Pharmacovigilance System Oversight | Zentiva Pharmacovigilance System | Pharmacovigilance |
|---|---|---|---|
| 情報源 | Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych (URPL) | Zentiva Group, a.s. | BASG - Bundesamt für Sicherheit im Gesundheitswesen |
| 説明 | Comprehensive regulatory management of the Polish drug safety framework, including the processing of Adverse Drug Reaction (ADR) reports from both patients and medical professionals, and conducting pharmacovigilance inspections of Marketing Authorisation Holders (MAHs) to ensure GVP compliance. | An internal pharmacovigilance management system overseen by an EU QPPV, dedicated to the monitoring and traceability of Zentiva's medicinal products. It facilitates the intake and evaluation of adverse event reports from global markets to maintain patient safety. | Système officiel autrichien pour la notification et l'évaluation des effets indésirables des médicaments humains et vétérinaires afin de garantir la sécurité continue des patients. |
| おすすめ用途 | Pharmaceutical companies, Healthcare professionals, Regulatory compliance と Adverse reaction reporting | Zentiva product users, Pharmacists, Drug safety monitoring と Adverse event intake | Signalement d'effets secondaires, Professionnels de santé, Patients autrichiens と Sécurité post Marché |
| 操作 | |||
| 評価 |
まずバランスのよい選択肢から見るなら、こちらがおすすめです:
"National Pharmacovigilance System Oversight 提供元 Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych (URPL)."
これを選んだ理由は It is the official regulatory body in Poland, providing the most authoritative and legally required infrastructure for reporting and monitoring drug safety.